Back to search

Article

Comparative effective dose of ciprofol and propofol in suppressing cardiovascular responses to tracheal intubation: a single-center, double-blind, randomized, controlled clinical trial

2024-02-13

Abstract excerpt

<title>Abstract</title> <p>Ciprofol, a novel γ-aminobutyric acid receptor agonist, outperforms propofol with minimal cardiovascular effects, higher potency, reduced injection pain, and a broader safety margin. Despite these advantages, ciprofol's clinical research is still emerging. This study compares the median effective dose (ED50) and adverse reactions of ciprofol and propofol, in conjunction with sufentanil,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e556c54a-be4d-5c88-bf76-c23ead6d56f9
DOI
10.21203/rs.3.rs-3904850/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Comparative effective dose of ciprofol and propofol in suppressing cardiovascular responses to tracheal intubation: a single-center, double-blind, randomized, controlled clinical trialDOI 10.21203/rs.3.rs-3904850/v1
Select a neighboring publication to make it the new centre.